Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Valles, Spain, Distributed by: Novartis Pharmaceuticals Corp., East Hanover, N.J. 07936, NDC 0078-1077-66
Published December 20, 2023 · Recall initiated: November 20, 2023
Summary
FDA records drug Class III recall D-0149-2024, published December 20, 2023 and initiated November 20, 2023. Recalling firm: Siegfried Barbera, SL; Status: Completed; Reported quantity: 2016; Lot: Lot# ME2713; Exp. 02/2025 Lot # MF8286, ML1860; Exp. 04/2025. Class III means the product is not likely to cause adverse health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications
What to do
Voluntary: Firm initiated
Get an email if VOTRIENT has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VOTRIENT
- Manufacturer
- Siegfried Barbera, SL
- Distributor
- Nationwide
- Lot
- Lot# ME2713; Exp. 02/2025 Lot # MF8286, ML1860; Exp. 04/2025
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- Spain
Related recalls
- FDAPenicillamine Tablets USP 250 mg, 100-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc.December 20, 2023
- FDALiothyronine Sodium Tablets, USP 5 mcg, 100-count bottle, Rx Only, Distributed by: Sun PharmaceuticalDecember 20, 2023
- FDATYSON 2.0, TYSON TONIC KAVA & KRATOM BLEND, Mocha, 2oz (60ml), Supplement Facts, Kava Root Extract (30%)December 20, 2023
- FDATYSON 2.0, TYSON TONIC KAVA & KRATOM BLEND, FRUIT PUNCH, 2oz (60ml), Supplement Facts, Kava Root Extract (30%)December 20, 2023
- FDAIntegra Cranial access kit (without Prep solutions) Bit and Guard-For access to the subarachnoid space or theDecember 13, 2023
- FDAvyaire Flexible Patient Circuit, 3100A, REF 29028-004, intended to be used with the 3100A High FrequencyDecember 13, 2023
Questions about this recall
Was Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Valles, Spain, Distributed by: Novartis Pharmaceuticals Corp., East Hanover, N.J. 07936, NDC 0078-1077-66 recalled?
Yes. FDA published recall D-0149-2024 on December 20, 2023. Reported hazard: Failed Dissolution Specifications
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VOTRIENT.